Intuitive Surgical ISRGHospitals and medical services
9.93 % of fund
Hospitals, medicines and medical equipment
MEGA 10 HEALTHCARE FUND
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
MEGA10HEALTH-A buys foreign shares directly
Intuitive Surgical ISRG9.93%
Thermo Fisher TMO9.89%
Stryker SYK9.79%
Eli Lilly and Co LLY9.72%
Danaher DHR9.71%Intuitive Surgical ISRGHospitals, medicines and medical equipment
Based on the fund's weights · top 5 stocks as of 30 Sep 2026 · AMC fact sheet · Illustrations are for explanation only, not individual stock recommendations
Over the past year it was in the top 25% of its group; there is no rank for a longer period yet
No. 1 is SCBGENOME(E) +62.13%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | MAX |
|---|---|---|---|---|---|---|---|
| +15.80% | +3.09% | +4.12% | +11.28% | +14.39% | +25.57% | +22.96% | +33.25% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun |
|---|
Largest drawdown in the selected period −14.50% Previous peak 25 Nov 2025 (NAV 12.0220) → Trough 11 May 2026 (NAV 10.2788) · Back to the previous peak on 11 Aug 2026, after 3 months
Currently −0.32% from the peak NAV of 13.3668 (2 Nov 2026)
Over 1 year, MEGA10HEALTH-A returned 1.21 per unit of volatility, ranking 13 of 40 funds · The highest is FP HCARE-A (1.64)
กองทุนมีนโยบายลงทุนในตราสารทุน และ/หรือ ใบรับฝากหลักทรัพย์ของสหรัฐอเมริกา (American Depositary Receipt (ADR)) ของบริษัทที่จดทะเบียนซื้อขายในตลาดหลักทรัพย์นิวยอร์ก (New York Stock Exchange: NYSE) หรือ ตลาดหลักทรัพย์แนสแด็ก (Nasdaq Stock Market: NASDAQ) หรือตลาดซื้อขายหลักทรัพย์อื่นใดในประเทศสหรัฐอเมร… Its largest holdings are INTUITIVE SURGICAL INC 9.93% · THERMO FISHER SCIENTIFIC INC 9.89% · STRYKER CORP 9.79% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 19 Jun 2025, its NAV has fallen as much as −14.50% from its peak.
Actual total expense ratio (TER) 2.20% a year, against a ceiling of 3.48%. Management fee 1.61%. Front-end fee 1.25%. Back-end fee 0.00%. (Fact sheet 31 Aug 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1,000 THB, subsequent purchases 1 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+2
Unhedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · MEGA10HEALTH-A: no dividends, TER 2.20% · MEGA10HEALTH-I: see the conditions in the prospectus · MEGA10HEALTH-P: see the conditions in the prospectus
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Thermo Fisher TMOAn American company selling scientific instruments, reagents and services for laboratories
Stryker SYKHospitals, medicines and medical equipment
Eli Lilly and Co LLYDiabetes and weight-loss drugs
Danaher DHRHospitals, medicines and medical equipment
| Jul |
|---|
| Aug |
|---|
| Sep |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Full year |
|---|
| 2026 | −2.5 | −0.9 | −1.3 | −3.2 | +1.9 | +6.5 | +1.6 | +4.1 | +0.5 | +8.7 | +0.2 | · | +15.8* |
| 2025 | · | · | · | · | · | −0.2 | +1.0 | +3.2 | −0.3 | +4.8 | +9.5 | −3.3 | +15.1* |